Clough Capital Partners L P Vertex Pharmaceuticals Inc Transaction History

Clough Capital Partners L P

  • $878 Million
  • Q2 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$314.42 - $351.91 $3.3 Million - $3.69 Million
-10,480 Reduced 28.7%
26,041 $9.16 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $3.03 Million - $3.45 Million
-10,690 Reduced 22.64%
36,521 $11.5 Million
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $9.3 Million - $10.5 Million
32,530 Added 221.58%
47,211 $13.6 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $429,913 - $479,682
-1,570 Reduced 9.66%
14,681 $4.25 Million
Q2 2022

Aug 16, 2022
SELL
$234.96 - $292.55 $9.84 Million - $12.3 Million
-41,899 Reduced 72.05%
16,251 $4.58 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $10.8 Million - $12.8 Million
-48,960 Reduced 45.71%
58,150 $15.2 Million
Q4 2021

Feb 14, 2022
BUY
$177.01 - $223.45 $3.1 Million - $3.91 Million
17,500 Added 19.53%
107,110 $23.5 Million
Q2 2021

Aug 16, 2021
BUY
$187.49 - $221.1 $1.56 Million - $1.84 Million
8,330 Added 10.25%
89,610 $18.1 Million
Q1 2021

May 17, 2021
SELL
$207.02 - $241.31 $1.1 Million - $1.28 Million
-5,320 Reduced 6.14%
81,280 $17.5 Million
Q4 2020

Feb 16, 2021
BUY
$207.01 - $276.09 $2.34 Million - $3.12 Million
11,290 Added 14.99%
86,600 $20.5 Million
Q3 2020

Nov 17, 2020
BUY
$255.65 - $303.1 $11.4 Million - $13.6 Million
44,710 Added 146.11%
75,310 $20.5 Million
Q2 2020

Aug 14, 2020
SELL
$225.48 - $295.8 $2.54 Million - $3.33 Million
-11,250 Reduced 26.88%
30,600 $8.88 Million
Q1 2020

May 15, 2020
BUY
$199.77 - $247.81 $1.02 Million - $1.27 Million
5,110 Added 13.91%
41,850 $9.96 Million
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $999,593 - $1.34 Million
5,996 Added 19.5%
36,740 $8.04 Million
Q3 2019

Nov 14, 2019
SELL
$166.23 - $187.09 $49,869 - $56,127
-300 Reduced 0.97%
30,744 $5.21 Million
Q2 2019

Aug 14, 2019
SELL
$164.61 - $190.37 $4.51 Million - $5.22 Million
-27,405 Reduced 46.89%
31,044 $5.69 Million
Q1 2019

May 15, 2019
BUY
$163.73 - $194.7 $2.24 Million - $2.66 Million
13,660 Added 30.5%
58,449 $10.8 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $140,212 - $177,409
-923 Reduced 2.02%
44,789 $7.42 Million
Q3 2018

Nov 14, 2018
SELL
$167.73 - $192.74 $922,515 - $1.06 Million
-5,500 Reduced 10.74%
45,712 $8.81 Million
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $1.14 Million - $1.33 Million
-7,830 Reduced 13.26%
51,212 $8.7 Million
Q1 2018

May 15, 2018
SELL
$151.6 - $177.13 $1.01 Million - $1.18 Million
-6,640 Reduced 10.11%
59,042 $9.62 Million
Q4 2017

Feb 14, 2018
BUY
$137.28 - $155.55 $384,384 - $435,540
2,800 Added 4.45%
65,682 $9.84 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $9.31 Million - $10.2 Million
62,882
62,882 $9.56 Million

Others Institutions Holding VRTX

# of Institutions
1,717
Shares Held
226M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email